Dept. of Epidemiology & Health Services Research
100 North Academy Avenue
Danville, PA 17822
Pre-Doctoral Fellowship, Criminology, New York University, 1974-1975
Ph.D., Social Psychology, New York University, 1974-1977
Post-Doctoral Fellowship, Psychiatry, West Haven VAMC & Yale University, 1977-1979
M.P.H., Epidemiology, University of California, Berkeley, 1992-1993
Post-Doctoral Fellowship, Epidemiology, University of California, San Francisco, 1992-1995
Epidemiology, Behavioral Health, Genetics, Pharmacogenetics, Neurosciences
Epidemiology; Behavioral Medicine; Behavior Genetics; Anxiety/Mood Disorders; Addictions; Psychometrics; Survey Research; Disasters; Veterans Health
Dr. Boscarino is a epidemiologist and social psychologist who is conducting research on liver disease epidemiology, post-traumatic stress disorder, addictions, and in behavioral genetics. In 2015, he is was awarded a US Department of Defense grant to investigate the health consequences of warzone deployments among Vietnam, Gulf War, and recent Global War on Terror (GWT) veterans. Dr. Boscarino is also the PI for the Naloxone Outcome Study funded by private industry and site PI for the Chronic Hepatitis Cohort Study-II (CHeCS-II), funded by the CDC. He is also site PI for a chronic hepatitis study examining the impact of direct-acting anti-viral (DAA) drugs on treatment outcomes funded by Gilead Sciences and site PI for the liver fibrosis study funded by Intercept Pharmaceuticals. He is also currently the site PI for the Addiction Research Network (ARN) study funded by NIDA and site PI for a Phase-IV post-marketing study of opoid misuse funded by FDA, as well as site PI for the CTN study funded by NIDA. Dr. Boscarino holds appointments at Mount Sinai School of Medicine (Internal Medicine and Pediatrics) and Temple University (Psychiatry). In 2009, he was elected to Fellow Status by the American Psychological Association (APA) and in 2010 he was given a Lifetime Achievement Award by the International Society of Traumatic Stress. In addition to APA, he is also a member of the Society of Biological Psychiatry, American College of Epidemiology, and is an Editor for the International Journal of Emergency Mental Health. From 2011-2016, he was appointed to committee membership on the National Academy of Sciences' SHAD-II Study, which investigated the long-term impact of chemical and biological weapons exposure among US military personnel during the cold war. In 2014, he was nominated for the Charles Shepard Science Award by the CDC for his chronic hepatitis research.
Boscarino JA, , Kirchner HL, Pitcavage JM, Nadipelli VR, Ronquest NA, Fitzpatrick MH, Han JJ.
Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system..
Subst Abuse Rehabil
, 7: 131-141.
Lu M, Li J, Rupp LB, Holmberg SD, Moorman AC, Spradling PR, Teshale EH, Zhou Y, Boscarino JA, Schmidt MA, Lamerato LE, Trinacty C, Trudeau S, Gordon SC; CHeCS Investigators.. (2016, Sept). Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma.. J Viral Hepat , 9: 718-729.
Boscarino JA ,Hoffman SN, Pitcavage JM, Urosevich TG. (2015). Mental Health Disorders and Treatment Seeking Among Veterans in Non-VA Facilities: Results and Implications from the Veterans' Health Study.. Mil Behav Health , 3(4):244-254.
Boscarino JA, Lu M, Moorman AC, Gordon SC, Rupp LB, Spradling PR, Teshale EH, Schmidt MA, Vijayadeva V, Holmberg SD. (2015, Mar). Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The chronic hepatitis cohort study (CHeCS). Hepatology , 61(3):802-11.
Boscarino JA, , Hoffman SN, Adams RE, Figley CR, Solhkhah R. (2014). Mental health outcomes among vulnerable residents after Hurricane Sandy: implications for disaster research and planning.. Am J Disaster Med , 9(2):107-120.